Bryan Hicks, MD
Dermatopathology · Ocala, FLNPI 1821086752
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $131 of the $176 with a category attached, or 74.3%. 7 manufacturers reported payments, led by Pfizer at 38.5% of the total. That places this record below the midpoint for dermatopathology clinicians in FL, where the typical reported total is $397.
Across 9 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$68
- Johnson & Johnson$23
- E.r. Squibb & Sons, L.L.C.$23
- Helsinn Therapeutics (U.S.), Inc.$17
- Strata Skin Sciences, Inc.$16
- Smith+Nephew$14
- plus $14 from 1 others
What the payments were for
- Food & beverage$13174%
- Education$4526%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $68 |
| Johnson & Johnson | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Strata Skin Sciences, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
How this compares
$176 in reported general payments places this provider in the 35th percentile of 62 dermatopathology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 110 | $8,463 |
| Azelaic Acid | 13 | $936 |
| Triamcinolone Acetonide | 86 | $890 |
| Metronidazole | 17 | $731 |
| Imiquimod | 25 | $598 |
| Fluocinonide | 15 | $521 |
| Terbinafine Hcl | 20 | $414 |
| Ketoconazole | 16 | $361 |
| Finasteride | 34 | $347 |
| Doxycycline Hyclate | 17 | $344 |
| Nystatin | 17 | $278 |
| Clobetasol Propionate | 13 | $271 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Ocala
- Rishi PatelBrooksville$38K
- John MillnsTampa$8K
- Daniel RivlinMiami Beach$3K
- Allison ArthurOrlando$3K
- Mustafa MohammadTampa$3K
- Andras SchafferTallahassee$3K
- Mazen DaoudFort Myers$2K
- Michael HennerMount Dora$2K
- Wonwoo ShonGainesville$1K
- Sairekha RavichandranTampa$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.